• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾组织中的簇集素:在肾小球中与终末补体复合物和免疫球蛋白沉积物的优先定位。

Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli.

作者信息

French L E, Tschopp J, Schifferli J A

机构信息

Department of Medicine, Hôpital Cantonal Universitaire, Geneva, Switzerland.

出版信息

Clin Exp Immunol. 1992 Jun;88(3):389-93. doi: 10.1111/j.1365-2249.1992.tb06459.x.

DOI:10.1111/j.1365-2249.1992.tb06459.x
PMID:1606720
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1554498/
Abstract

The membrane attack complex (MAC) of complement is activated by immune and non-immune mechanisms in the kidney. MAC has been found associated with glomerular immune deposits, but also to cell remnants, particularly along tubules and in vessel walls. Clusterin and S-protein (vitronectin) bind to MAC, rendering it cytolytically inactive. Both have been found associated with MAC in renal tissue. Here we analysed the deposition of clusterin and S-protein in 118 renal biopsies relative to the localization of the MAC using MoAbs. Statistical analysis was performed comparing no or little versus evident or strong staining by immunofluorescence (IF). In glomeruli, out of the 92 biopsies where both MAC and immunoglobulins were evaluated, deposits of MAC were found in the presence (32 out of 41) but also in the absence of immunoglobulins (20/51). Clusterin and S-protein deposits were seen, respectively, in 25 out of 61 and 36 out of 61 biopsies containing glomerular MAC, and almost never in its absence (one out of 50 for both). The association of the two inhibitors with MAC was observed mainly in glomeruli containing immunoglobulin deposits (respectively, 21 out of 32 and 25 out of 32), but not when immunoglobulins were absent (three out of 20 and seven out of 20) (coefficient of concordance, K = 0.47 and 0.43). The localization of MAC along tubules and in vessels was easily identified in most biopsies (93 out of 118) and was accompanied by S-protein in most cases (tubules, 86 out of 93; vessels, 82 out of 93) (K = 0.58 and 0.57 respectively) but not by clusterin (28 out of 93 and 24 out of 93). These results suggest that clusterin does not co-localize with MAC whenever there is formation and fixation of the MAC. It seems that clusterin has a particular affinity for MAC which is associated with immunoglobulin. This observation should help to distinguish between the different forms of MAC, and might indicate that MAC associated with immunoglobulin is essentially in its cytolytically inactive form.

摘要

补体膜攻击复合物(MAC)在肾脏中可通过免疫和非免疫机制被激活。已发现MAC与肾小球免疫沉积物相关,但也与细胞残余物相关,特别是沿肾小管和血管壁处。簇集素和S蛋白(玻连蛋白)与MAC结合,使其失去细胞溶解活性。在肾组织中均已发现它们与MAC相关。在此,我们使用单克隆抗体(MoAbs)分析了118例肾活检组织中簇集素和S蛋白的沉积情况,并与MAC的定位进行了对比。通过免疫荧光(IF)对无或少量染色与明显或强染色进行比较,进行了统计学分析。在肾小球中,在评估了MAC和免疫球蛋白的92例活检组织中,MAC沉积物在有免疫球蛋白存在时(41例中有32例)以及无免疫球蛋白时(51例中有20例)均被发现。在含有肾小球MAC的61例活检组织中,分别有25例和36例可见簇集素和S蛋白沉积物,而在无MAC时几乎未见(两者均为50例中有1例)。两种抑制剂与MAC的关联主要在含有免疫球蛋白沉积物的肾小球中观察到(分别为32例中有21例和32例中有25例),而在无免疫球蛋白时则未观察到(20例中有3例和20例中有7例)(一致性系数,K = 0.47和0.43)。在大多数活检组织(118例中有93例)中,很容易识别出沿肾小管和血管的MAC定位,并且在大多数情况下伴有S蛋白(肾小管,93例中有86例;血管,93例中有82例)(K分别为0.58和0.57),但簇集素则不然(93例中有28例和93例中有24例)。这些结果表明,每当MAC形成并固定时,簇集素并不与MAC共定位。似乎簇集素对与免疫球蛋白相关的MAC具有特殊亲和力。这一观察结果应有助于区分MAC的不同形式,并且可能表明与免疫球蛋白相关的MAC基本上处于其细胞溶解无活性形式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b9/1554498/22134c3ffd6f/clinexpimmunol00050-0019-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b9/1554498/de6ab9a3aa28/clinexpimmunol00050-0019-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b9/1554498/22134c3ffd6f/clinexpimmunol00050-0019-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b9/1554498/de6ab9a3aa28/clinexpimmunol00050-0019-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b9/1554498/22134c3ffd6f/clinexpimmunol00050-0019-b.jpg

相似文献

1
Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli.肾组织中的簇集素:在肾小球中与终末补体复合物和免疫球蛋白沉积物的优先定位。
Clin Exp Immunol. 1992 Jun;88(3):389-93. doi: 10.1111/j.1365-2249.1992.tb06459.x.
2
Membrane attack complex (MAC) deposits in skin are not always accompanied by S-protein and clusterin.膜攻击复合物(MAC)在皮肤中的沉积并不总是伴有S蛋白和簇集素。
J Invest Dermatol. 1992 May;98(5):758-63. doi: 10.1111/1523-1747.ep12499946.
3
Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.终末补体成分S蛋白和SP-40,40在肾活检组织中的定位
Pathology. 1989 Oct;21(4):275-8. doi: 10.3109/00313028909061073.
4
Expression of the complement membrane attack complex and its inhibitors in Pick disease brain.补体膜攻击复合物及其抑制剂在匹克病大脑中的表达。
Brain Res. 1994 Aug 1;652(2):346-9. doi: 10.1016/0006-8993(94)90246-1.
5
Localization of clusterin in the epimembranous deposits of passive Heymann nephritis.簇集素在被动型海曼肾炎的膜上沉积物中的定位
Kidney Int. 1991 Feb;39(2):247-52. doi: 10.1038/ki.1991.29.
6
Localization of the membrane attack complex (MAC) in experimental immune complex glomerulonephritis.膜攻击复合物(MAC)在实验性免疫复合物肾小球肾炎中的定位
J Exp Med. 1983 Jun 1;157(6):1885-905. doi: 10.1084/jem.157.6.1885.
7
Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).循环免疫复合物(CIC)上存在血浆补体调节蛋白簇集素(载脂蛋白J)和玻连蛋白(S40)。
Clin Exp Immunol. 2006 Sep;145(3):398-406. doi: 10.1111/j.1365-2249.2006.03135.x.
8
Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis.系统性红斑狼疮性肾炎中膜攻击复合物的肾脏定位
J Exp Med. 1981 Dec 1;154(6):1779-94. doi: 10.1084/jem.154.6.1779.
9
Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction.在心肌梗死中,簇集素与补体膜攻击复合物的共沉积。
Immunology. 1993 Oct;80(2):177-82.
10
Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury.在补体介导的损伤中,簇集素在肾小球系膜细胞中上调。
Kidney Int. 2001 Jan;59(1):137-46. doi: 10.1046/j.1523-1755.2001.00474.x.

引用本文的文献

1
The Most Promising Biomarkers of Allogeneic Kidney Transplant Rejection.同种异体肾移植排斥反应最有前途的生物标志物。
J Immunol Res. 2022 May 28;2022:6572338. doi: 10.1155/2022/6572338. eCollection 2022.
2
Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.健康和患病人类肾脏中膜攻击复合物的沉积。
Front Immunol. 2021 Feb 11;11:599974. doi: 10.3389/fimmu.2020.599974. eCollection 2020.
3
Urinary Clusterin Is Upregulated in Nephropathia Epidemica.尿簇集蛋白在流行性肾病中上调。

本文引用的文献

1
Terminal membrane C5b-9 complex of human complement: transition from an amphiphilic to a hydrophilic state through binding of the S protein from serum.人补体终末膜C5b-9复合物:通过与血清中的S蛋白结合从两亲状态转变为亲水状态。
J Cell Biol. 1982 Sep;94(3):755-9. doi: 10.1083/jcb.94.3.755.
2
Formation of transmembrane tubules by spontaneous polymerization of the hydrophilic complement protein C9.亲水性补体蛋白C9通过自发聚合形成跨膜小管。
Nature. 1982 Aug 5;298(5874):534-8. doi: 10.1038/298534a0.
3
Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
Dis Markers. 2018 Feb 26;2018:8658507. doi: 10.1155/2018/8658507. eCollection 2018.
4
Primary Membranous Nephropathy.原发性膜性肾病
Clin J Am Soc Nephrol. 2017 Jun 7;12(6):983-997. doi: 10.2215/CJN.11761116. Epub 2017 May 26.
5
CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.CD47缺陷通过抑制IgG自身抗体产生改善Fas(lpr)小鼠的自身免疫性肾炎。
J Pathol. 2015 Nov;237(3):285-95. doi: 10.1002/path.4574. Epub 2015 Jul 14.
6
Identification of human plasma proteins as major clients for the extracellular chaperone clusterin.鉴定人血浆蛋白作为细胞外伴侣蛋白聚糖的主要客户。
J Biol Chem. 2010 Feb 5;285(6):3532-3539. doi: 10.1074/jbc.M109.079566. Epub 2009 Dec 7.
7
Structural characterization of clusterin-chaperone client protein complexes.簇集素伴侣蛋白复合物的结构表征
J Biol Chem. 2009 Aug 14;284(33):21920-21927. doi: 10.1074/jbc.M109.033688. Epub 2009 Jun 17.
8
Presence of plasma complement regulatory proteins clusterin (Apo J) and vitronectin (S40) on circulating immune complexes (CIC).循环免疫复合物(CIC)上存在血浆补体调节蛋白簇集素(载脂蛋白J)和玻连蛋白(S40)。
Clin Exp Immunol. 2006 Sep;145(3):398-406. doi: 10.1111/j.1365-2249.2006.03135.x.
9
Complement and systemic lupus erythematosus.补体与系统性红斑狼疮
Arthritis Res. 2002;4 Suppl 3(Suppl 3):S279-93. doi: 10.1186/ar586. Epub 2002 May 9.
10
Tubular up-regulation of clusterin mRNA in murine lupus-like nephritis.小鼠狼疮样肾炎中簇集蛋白mRNA的肾小管上调
Am J Pathol. 1998 Apr;152(4):953-62.
补体第九聚合成分的新抗原。一种单克隆抗体的特性及在肾脏疾病中的免疫组织化学定位。
J Clin Invest. 1983 Aug;72(2):560-73. doi: 10.1172/JCI111004.
4
Role of the terminal complement pathway in experimental membranous nephropathy in the rabbit.终末补体途径在兔实验性膜性肾病中的作用
J Clin Invest. 1983 Dec;72(6):1948-57. doi: 10.1172/JCI111159.
5
Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.补体膜攻击复合物中C9的分子组织。C5b-8组装诱导C9环状聚合。
J Exp Med. 1982 Jul 1;156(1):268-82. doi: 10.1084/jem.156.1.268.
6
Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma.识别聚(C9)新抗原的单克隆抗体可在组织和血浆中检测到人末端补体复合物。
Scand J Immunol. 1985 Aug;22(2):183-95. doi: 10.1111/j.1365-3083.1985.tb01870.x.
7
Role of terminal complement pathway in the heterologous phase of antiglomerular basement membrane nephritis.终末补体途径在抗肾小球基底膜肾炎异源期的作用。
Kidney Int. 1985 Apr;27(4):643-51. doi: 10.1038/ki.1985.59.
8
Electroimmunoassay-immunoblotting (EIA-IB) for the utilization of monoclonal antibodies in quantitative immunoelectrophoresis: the method and its applications.用于在定量免疫电泳中利用单克隆抗体的电免疫测定-免疫印迹法(EIA-IB):方法及其应用。
J Immunol Methods. 1985 Jun 12;80(1):25-32. doi: 10.1016/0022-1759(85)90160-7.
9
Ultrastructural localization of the membrane attack complex of complement in human renal tissues.
Am J Kidney Dis. 1987 Feb;9(2):121-8. doi: 10.1016/s0272-6386(87)80089-6.
10
Immunohistochemical study of the C5b-9 complex of complement in human kidneys.人肾补体C5b - 9复合物的免疫组织化学研究
Kidney Int. 1986 Sep;30(3):399-410. doi: 10.1038/ki.1986.198.